Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00149734
Show Display Options
RSS Create an RSS feed from your search for:
NCT00149734
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Ondansetron followed by placebo;   Drug: Placebo followed by Ondansetron

Study has passed its completion date and status has not been verified in more than two years.